Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tela Bio Inc (NQ: TELA ) 5.720 +0.010 (+0.18%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 159,877 Open 5.760 Bid (Size) 5.700 (2) Ask (Size) 5.720 (7) Prev. Close 5.710 Today's Range 5.440 - 5.795 52wk Range 4.235 - 11.26 Shares Outstanding 24,655,371 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News TELA Bio Appoints Jeffrey Blizard to its Board of Directors June 04, 2024 From TELA Bio, Inc. Via GlobeNewswire TELA Bio Appoints Greg Firestone as Chief Commercial Officer May 20, 2024 From TELA Bio, Inc. Via GlobeNewswire Performance YTD -13.60% -13.60% 1 Month +24.62% +24.62% 3 Month -13.98% -13.98% 6 Month +4.95% +4.95% 1 Year -47.28% -47.28% More News Read More TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 10, 2024 From TELA Bio, Inc. Via GlobeNewswire Recap: TELA Bio Q4 Earnings March 21, 2024 Via Benzinga Preview: TELA Bio's Earnings March 20, 2024 Via Benzinga Recap: TELA Bio Q3 Earnings November 09, 2023 Via Benzinga TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q1 2024 May 09, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session May 09, 2024 Via Benzinga TELA Bio Reports First Quarter 2024 Financial Results May 09, 2024 From TELA Bio, Inc. Via GlobeNewswire TELA Bio to Announce First Quarter 2024 Financial Results April 25, 2024 From TELA Bio, Inc. Via GlobeNewswire TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures April 15, 2024 From TELA Bio, Inc. Via GlobeNewswire TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy April 08, 2024 From TELA Bio, Inc. Via GlobeNewswire TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023 March 21, 2024 Via InvestorPlace TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery March 21, 2024 From TELA Bio, Inc. Via GlobeNewswire TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX March 20, 2024 From TELA Bio, Inc. Via GlobeNewswire Earnings Scheduled For March 21, 2024 March 21, 2024 Via Benzinga TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results February 29, 2024 From TELA Bio, Inc. Via GlobeNewswire TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 23, 2024 From TELA Bio, Inc. Via GlobeNewswire TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 19, 2024 From TELA Bio, Inc. Via GlobeNewswire TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 15, 2023 From TELA Bio, Inc. Via GlobeNewswire TELA Bio to Take Part in Connecting the Dots December 05, 2023 From TELA Bio, Inc. Via GlobeNewswire TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference November 16, 2023 From TELA Bio, Inc. Via GlobeNewswire TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 10, 2023 From TELA Bio, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session November 09, 2023 Via Benzinga TELA Bio Reports Third Quarter 2023 Financial Results November 09, 2023 From TELA Bio, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
